NCT00768911 2010-10-27CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma MultiformeAdnexus, A Bristol-Myers Squibb R&D CompanyPhase 1 Unknown30 enrolled